Sun Pharmaceuticals reported INR71.04B in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aspen Pharmacare APN:SJ 8.6B 583M
Bharat Petroleum BPCL:IN 103.7B 20.74B
Cipla CIPLA:IN 33.83B 524M
Dr.Reddys Laboratories DRRD:IN 37.59B 5.16B
Jiangsu Hengrui Me. 600276:CH CH 5.88B 399.7M
Reliance Infra RELI:IN IR 541820M 45380M
Sh Fosun Pharma 600196:CH CH 4.77B 216.37M
Sun Pharmaceuticals SUNP:IN IR 71040.7M 347.6M
UPL UPLL:IN 53.46B 5.34B